Global Tuberculosis Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 161204
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 119
  • list Pharmaceuticals and Healthcare

Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at an advanced stage the sputum will contain blood and other symptoms include lack of appetite, weight loss, fever, and night sweats.

Scope of the Report:

The worldwide market for Tuberculosis Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Tuberculosis Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Sanofi

Merck

Serum Institute of India

GlaxoSmithKline

Japan BCG Lab

IDT Biologics

GreenSignal Bio Pharma

Taj Pharmaceuticals

Bavarian Nordic

China National Biotec Group

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Immunotherapeutic Vaccines

Booster Vaccines

Others

Market Segment by Applications, can be divided into

Hospitals

Clinics

Others

There are 15 Chapters to deeply display the global Tuberculosis Vaccines market.

Chapter 1, to describe Tuberculosis Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Tuberculosis Vaccines, with sales, revenue, and price of Tuberculosis Vaccines, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Tuberculosis Vaccines, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Tuberculosis Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Tuberculosis Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Tuberculosis Vaccines Introduction

1.2 Market Analysis by Type

1.2.1 Immunotherapeutic Vaccines

1.2.2 Booster Vaccines

1.2.3 Others

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Clinics

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Sanofi

2.1.1 Business Overview

2.1.2 Tuberculosis Vaccines Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Sanofi Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Merck

2.2.1 Business Overview

2.2.2 Tuberculosis Vaccines Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Merck Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Serum Institute of India

2.3.1 Business Overview

2.3.2 Tuberculosis Vaccines Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Serum Institute of India Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 GlaxoSmithKline

2.4.1 Business Overview

2.4.2 Tuberculosis Vaccines Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 GlaxoSmithKline Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Japan BCG Lab

2.5.1 Business Overview

2.5.2 Tuberculosis Vaccines Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Japan BCG Lab Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 IDT Biologics

2.6.1 Business Overview

2.6.2 Tuberculosis Vaccines Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 IDT Biologics Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 GreenSignal Bio Pharma

2.7.1 Business Overview

2.7.2 Tuberculosis Vaccines Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 GreenSignal Bio Pharma Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Taj Pharmaceuticals

2.8.1 Business Overview

2.8.2 Tuberculosis Vaccines Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Taj Pharmaceuticals Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Bavarian Nordic

2.9.1 Business Overview

2.9.2 Tuberculosis Vaccines Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Bavarian Nordic Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 China National Biotec Group

2.10.1 Business Overview

2.10.2 Tuberculosis Vaccines Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 China National Biotec Group Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Tuberculosis Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Tuberculosis Vaccines Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Tuberculosis Vaccines Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Tuberculosis Vaccines Manufacturer Market Share in 2017

3.3.2 Top 6 Tuberculosis Vaccines Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Tuberculosis Vaccines Market Analysis by Regions

4.1 Global Tuberculosis Vaccines Sales, Revenue and Market Share by Regions

4.1.1 Global Tuberculosis Vaccines Sales and Market Share by Regions (2013-2018)

4.1.2 Global Tuberculosis Vaccines Revenue and Market Share by Regions (2013-2018)

4.2 North America Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

4.3 Europe Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

4.5 South America Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

5 North America Tuberculosis Vaccines by Countries

5.1 North America Tuberculosis Vaccines Sales, Revenue and Market Share by Countries

5.1.1 North America Tuberculosis Vaccines Sales and Market Share by Countries (2013-2018)

5.1.2 North America Tuberculosis Vaccines Revenue and Market Share by Countries (2013-2018)

5.2 United States Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

5.3 Canada Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

5.4 Mexico Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

6 Europe Tuberculosis Vaccines by Countries

6.1 Europe Tuberculosis Vaccines Sales, Revenue and Market Share by Countries

6.1.1 Europe Tuberculosis Vaccines Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Tuberculosis Vaccines Revenue and Market Share by Countries (2013-2018)

6.2 Germany Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

6.3 UK Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

6.4 France Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

6.5 Russia Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

6.6 Italy Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

7 Asia-Pacific Tuberculosis Vaccines by Countries

7.1 Asia-Pacific Tuberculosis Vaccines Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Tuberculosis Vaccines Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Tuberculosis Vaccines Revenue and Market Share by Countries (2013-2018)

7.2 China Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

7.3 Japan Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

7.4 Korea Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

7.5 India Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

8 South America Tuberculosis Vaccines by Countries

8.1 South America Tuberculosis Vaccines Sales, Revenue and Market Share by Countries

8.1.1 South America Tuberculosis Vaccines Sales and Market Share by Countries (2013-2018)

8.1.2 South America Tuberculosis Vaccines Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

8.3 Argentina Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

8.4 Colombia Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

9 Middle East and Africa Tuberculosis Vaccines by Countries

9.1 Middle East and Africa Tuberculosis Vaccines Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Tuberculosis Vaccines Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Tuberculosis Vaccines Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

9.3 UAE Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

9.4 Egypt Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

9.5 Nigeria Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

9.6 South Africa Tuberculosis Vaccines Sales and Growth Rate (2013-2018)

10 Global Tuberculosis Vaccines Market Segment by Type

10.1 Global Tuberculosis Vaccines Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Tuberculosis Vaccines Sales and Market Share by Type (2013-2018)

10.1.2 Global Tuberculosis Vaccines Revenue and Market Share by Type (2013-2018)

10.2 Immunotherapeutic Vaccines Sales Growth and Price

10.2.1 Global Immunotherapeutic Vaccines Sales Growth (2013-2018)

10.2.2 Global Immunotherapeutic Vaccines Price (2013-2018)

10.3 Booster Vaccines Sales Growth and Price

10.3.1 Global Booster Vaccines Sales Growth (2013-2018)

10.3.2 Global Booster Vaccines Price (2013-2018)

10.4 Others Sales Growth and Price

10.4.1 Global Others Sales Growth (2013-2018)

10.4.2 Global Others Price (2013-2018)

11 Global Tuberculosis Vaccines Market Segment by Application

11.1 Global Tuberculosis Vaccines Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Clinics Sales Growth (2013-2018)

11.4 Others Sales Growth (2013-2018)

12 Tuberculosis Vaccines Market Forecast (2018-2023)

12.1 Global Tuberculosis Vaccines Sales, Revenue and Growth Rate (2018-2023)

12.2 Tuberculosis Vaccines Market Forecast by Regions (2018-2023)

12.2.1 North America Tuberculosis Vaccines Market Forecast (2018-2023)

12.2.2 Europe Tuberculosis Vaccines Market Forecast (2018-2023)

12.2.3 Asia-Pacific Tuberculosis Vaccines Market Forecast (2018-2023)

12.2.4 South America Tuberculosis Vaccines Market Forecast (2018-2023)

12.2.5 Middle East and Africa Tuberculosis Vaccines Market Forecast (2018-2023)

12.3 Tuberculosis Vaccines Market Forecast by Type (2018-2023)

12.3.1 Global Tuberculosis Vaccines Sales Forecast by Type (2018-2023)

12.3.2 Global Tuberculosis Vaccines Market Share Forecast by Type (2018-2023)

12.4 Tuberculosis Vaccines Market Forecast by Application (2018-2023)

12.4.1 Global Tuberculosis Vaccines Sales Forecast by Application (2018-2023)

12.4.2 Global Tuberculosis Vaccines Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Tuberculosis Vaccines Picture

Table Product Specifications of Tuberculosis Vaccines

Figure Global Sales Market Share of Tuberculosis Vaccines by Types in 2017

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery